BioNTech’s CEO and his fellow co-founder will depart the biopharma by the end of the year to head up a new company focused on “next generation mRNA innovations.” Uğur Şahin, M.D., who is currently the ...
BioNTech founders to start new company by end-2026 New venture to focus on mRNA-based next-gen drugs Shares plunge 21% to their lowest since August 2024 Sahin and Tuereci plan to work on early drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results